CNMD

Conmed Corp

• Simply Wall St·2d ago

  Is CONMED’s (CNMD) Earnings Beat And Higher Sales Outlook Reframing Its Core Investment Story?

• Simply Wall St·4d ago

  CONMED (CNMD) Lifts Sales Outlook, Is The Stock 24% Overvalued?

• Simply Wall St·08/01 19:17

  CONMED (CNMD) Is Up 8.5% After Raising 2026 Sales Guidance Has The Bull Case Changed?

• Simply Wall St·07/30 22:16

  CONMED (CNMD) Stock Rallies On Profit Strength While Debt Still Looms

• Benzinga·07/30 18:13

  Piper Sandler Reiterates Neutral on Conmed, Raises Price Target to $45

• TipRanks·07/30 16:50

  Analysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD)

• Dow Jones·07/30 14:16

  Conmed Is Maintained at Equal-Weight by Wells Fargo

• Dow Jones·07/30 14:16

  Conmed Price Target Raised to $46.00/Share From $39.00 by Wells Fargo

• Benzinga·07/30 14:09

  Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46

• TipRanks·07/30 13:20

  Conmed price target raised to $45 from $40 at JPMorgan

• TipRanks·07/30 11:20

  Analysts Conflicted on These Healthcare Names: Hims & Hers Health (HIMS), Conmed (CNMD) and Guardant Health (GH)

• Seeking Alpha·07/30 11:11

  At a glance: stocks gapping up premarket

• TipRanks·07/30 09:35

  Conmed: Solid 2Q Beat and Higher EPS Guidance, But Trimmed Organic Growth Outlook Keeps Matson at Hold

• NASDAQ·07/29 22:30

  Conmed (CNMD) Reports Q2 Earnings: What Key Metrics Have to Say

• NASDAQ·07/29 22:25

  Conmed (CNMD) Q2 Earnings and Revenues Top Estimates